Rigel Pharmaceuticals Inc Capital Reinvestment Ratio
Rigel Pharmaceuticals Inc capital reinvestment ratio. Rigel Pharmaceuticals Inc (RIGL) has a Capital Reinvestment Ratio of 0.00x as of December 2025, meaning it reinvests 0% of its operating cash flow ($21.98 Million) in capital expenditures ($12.00K). Check cash flow reinvestment rate of Rigel Pharmaceuticals Inc to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Rigel Pharmaceuticals Inc (2010–2024)
Capital reinvestment ratio of Rigel Pharmaceuticals Inc from 2010 to 2024. This chart tracks Rigel Pharmaceuticals Inc's Capital Reinvestment Ratio across 3 annual periods. Also explore Rigel Pharmaceuticals Inc equity growth rate to track the company's year-over-year net asset growth rate.
Rigel Pharmaceuticals Inc Capital Reinvestment Ratio by Year (2010–2024)
Rigel Pharmaceuticals Inc capital reinvestment ratio by year from 2010 to 2024. For the full cash flow conversion analysis, see Rigel Pharmaceuticals Inc (RIGL) cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.01x | $31.47 Million | $396.00K | ▼ -88.2% |
| 2021 | 0.11x | $5.88 Million | $627.00K | ▲ +40.1% |
| 2010 | 0.08x | $46.74 Million | $3.56 Million | — |